Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-06 Sale |
2023-06-08 7:00 pm |
Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
403,758 | $6.2732 | $2,532,858 | 22,546,725 (Indirect) |
View |
| 2023-05-24 Sale |
2023-05-26 8:00 pm |
Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
545,242 | $6.4692 | $3,527,275 | 22,591,782 (Indirect) |
View |
| 2022-09-15 Purchase |
2022-09-16 7:30 pm |
Codiak BioSciences Inc. | CDAK | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
933,333 | $0 | $0 | 2,608,202 (Indirect) |
View |
| 2021-08-03 Purchase |
2021-08-05 5:43 pm |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC 10% Owner |
1,176,469 | $17 | $19,999,973 | 3,814,705 (Indirect) |
View |
| 2020-10-16 Purchase |
2020-10-20 8:05 pm |
Codiak BioSciences Inc. | CDAK | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
165,000 | $15 | $2,475,000 | 1,629,126 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion